Skip to main content

Iron Deficiency

2
Pipeline Programs
6
Companies
11
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
7 programs
1
Fer-in-SolPhase 41 trial
Fer-In-SolN/A1 trial
Ferrous SulfateN/A1 trial
Ferrous sulfateN/A1 trial
Immediate ironN/A1 trial
+2 more programs
Active Trials
NCT00760890Completed171Est. Oct 2005
NCT00642863Completed1,614Est. Jun 2014
NCT01156896Completed23Est. Jul 2014
+4 more trials
Enterprise Therapeutics
1 program
1
Mineral-enriched powderPhase 21 trial
Active Trials
NCT05990166Completed150Est. Mar 2026
Alliance Pharmaceuticals
1 program
Fortified riceN/A1 trial
Active Trials
NCT02572128Completed44Est. Dec 2015
Gedeon Richter
Gedeon RichterHungary - Budapest
1 program
Globifer ForteN/A1 trial
Active Trials
NCT03055559Completed60Est. May 2017
Parexel
ParexelMA - Boston
1 program
FerinjectPHASE_31 trial
Active Trials
NCT00810004Completed245Est. Oct 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesFer-in-Sol
ParexelFerinject
Enterprise TherapeuticsMineral-enriched powder
Gedeon RichterGlobifer Forte
Alliance PharmaceuticalsFortified rice
Human BioSciencesImmediate iron
Human BioSciencesFerrous sulfate
Human BioSciencesWater
Human BioSciencesFerrous Sulfate
Human BioScienceselectrolytic iron
Human BioSciencesFer-In-Sol

Clinical Trials (11)

Total enrollment: 3,161 patients across 11 trials

NCT01444261Human BioSciencesFer-in-Sol

Prevention of Iron Deficiency in Breastfed Infants

Start: Dec 2010Est. completion: Apr 2014219 patients
Phase 4Completed
NCT00810004ParexelFerinject

Maintenance Treatment of Iron Deficiency in IBD Patients

Start: Feb 2009Est. completion: Oct 2010245 patients
Phase 3Completed
NCT05990166Enterprise TherapeuticsMineral-enriched powder

Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age

Start: Apr 2023Est. completion: Mar 2026150 patients
Phase 2Completed
NCT03055559Gedeon RichterGlobifer Forte

Trial Protocol GlobiFer - Oral Iron Repletion

Start: Jun 2016Est. completion: May 201760 patients
N/ACompleted
NCT02572128Alliance PharmaceuticalsFortified rice

Mineral Absorption From Fortified Rice Produced With Different Fortification Techniques

Start: Jun 2015Est. completion: Dec 201544 patients
N/ACompleted
NCT01754701Human BioSciencesImmediate iron

Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe Malaria

Start: Jun 2013Est. completion: May 2015100 patients
N/ACompleted
NCT01156896Human BioSciencesFerrous sulfate

Malaria and the Safety of Iron Supplements and Iron Fortification

Start: Jul 2010Est. completion: Jul 201423 patients
N/ACompleted
NCT02728141Human BioSciencesWater

Healthy Infant Development Project - Sucrose Component

Start: Nov 2009Est. completion: Jun 2014424 patients
N/ACompleted
NCT00642863Human BioSciencesFerrous Sulfate

Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants

Start: Apr 2008Est. completion: Jun 20141,614 patients
N/ACompleted
NCT00841061Human BioScienceselectrolytic iron

Cereals as a Source of Iron for Breastfed Infants

Start: Jul 2003Est. completion: May 2006111 patients
N/ACompleted
NCT00760890Human BioSciencesFer-In-Sol

Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation

Start: Jun 2001Est. completion: Oct 2005171 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.